Josephine Bunch | |
---|---|
Alma mater | Sheffield Hallam University |
Scientific career | |
Institutions |
National Physical Laboratory (United Kingdom) University of Sheffield |
Thesis | Detection and imaging of pharmaceutical compounds in skin by MALDI-MS (2005) |
Josephine Bunch is a fellow at the National Physical Laboratory. She is Chair of Biomolecular Mass Spectrometry at Imperial College London and the Co-Director of the National Centre of Excellence in Mass Spectrometry Imaging.
Bunch completed a PhD sponsored by Pfizer at Sheffield Hallam University in 2005. [1] Her thesis, "Detection and imaging of pharmaceutical compounds in skin by MALDI-MS", used mass spectrometry. [2]
Bunch was a postdoctoral researcher at the University of Sheffield, where she was awarded an Enterprise Fellowship to commercialise imaging using mass spectrometry. [1] She joined the University of Birmingham, leading a large multi-disciplinary group using MALDI Mass spectrometry. [3] [4] She remains an honorary senior research fellow at the University of Birmingham. [5] She also holds a Chair in Biomolecular Mass Spectrometry at Imperial College London. [6]
She joined the National Physical Laboratory in 2013, where she became responsible for research in MALDI metrology. [4] [7] In 2017 Bunch was funded by Cancer Research UK's Grand Challenge to map tumours at a molecular and cellular level. [8] She came up with the idea when listening to a BBC Radio 4 program about the Cancer Research UK Grand Challenges. [9] The investment was worth £16 million, and uses mass spectrometry imaging techniques to study breast, bowel and pancreatic tumours in "unprecedented detail. [10] [11] [12] [13] [14] She spoke about the project at the Hay Festival and presented their project at the Royal Society Summer Exhibition. [15] [16] [17]
She is part of a COST ( European Cooperation in Science and Technology) Action on mass spectrometry imaging. [18] [3]
Josephine Bunch | |
---|---|
Alma mater | Sheffield Hallam University |
Scientific career | |
Institutions |
National Physical Laboratory (United Kingdom) University of Sheffield |
Thesis | Detection and imaging of pharmaceutical compounds in skin by MALDI-MS (2005) |
Josephine Bunch is a fellow at the National Physical Laboratory. She is Chair of Biomolecular Mass Spectrometry at Imperial College London and the Co-Director of the National Centre of Excellence in Mass Spectrometry Imaging.
Bunch completed a PhD sponsored by Pfizer at Sheffield Hallam University in 2005. [1] Her thesis, "Detection and imaging of pharmaceutical compounds in skin by MALDI-MS", used mass spectrometry. [2]
Bunch was a postdoctoral researcher at the University of Sheffield, where she was awarded an Enterprise Fellowship to commercialise imaging using mass spectrometry. [1] She joined the University of Birmingham, leading a large multi-disciplinary group using MALDI Mass spectrometry. [3] [4] She remains an honorary senior research fellow at the University of Birmingham. [5] She also holds a Chair in Biomolecular Mass Spectrometry at Imperial College London. [6]
She joined the National Physical Laboratory in 2013, where she became responsible for research in MALDI metrology. [4] [7] In 2017 Bunch was funded by Cancer Research UK's Grand Challenge to map tumours at a molecular and cellular level. [8] She came up with the idea when listening to a BBC Radio 4 program about the Cancer Research UK Grand Challenges. [9] The investment was worth £16 million, and uses mass spectrometry imaging techniques to study breast, bowel and pancreatic tumours in "unprecedented detail. [10] [11] [12] [13] [14] She spoke about the project at the Hay Festival and presented their project at the Royal Society Summer Exhibition. [15] [16] [17]
She is part of a COST ( European Cooperation in Science and Technology) Action on mass spectrometry imaging. [18] [3]